HCT Matched Related Hematopoietic Stem Cell Tranplantation for Children with Less Severe Sickle Cell Disease: a Sickle Transplant Alliance for Research (STAR) Trial
STAR HCST for Less Severe Sickle Cell Disease (SCD)
Sponsor: STAR
Enrolling: Male and Female Patients
Study Length: 2 Years
IRB Number: AAAS6455
Contact: Brian Volonte: 212-304-7806 / bv2272@cumc.columbia.edu
Additional Study Information: The primary objectives of this study are to measure the safety and effectiveness of bone marrow transplant (BMT) using specific chemotherapy in children with less severe SCD and to understand the long term effects of bone marrow transplant in children with SCD, by evaluating ovarian reserve, sickle cell related brain problems, sickle cell related kidney problems and health related quality of life.
This study is closed
Investigator
Monica Bhatia, MD
Do You Qualify?
Hgb SS or HbS Beta Thalassemia Yes No
HLA identical donor Yes No
Previous stroke or abnormal TCD Yes No
Frequent (3/year for preceeding 2 years) VOCs or Acute Chest Events Yes No
Normal organ function Yes No
Submit
Cancel
You may be eligible for this study

Place Holder



Cancel
For more information, please contact:
Brian Volonte
bv2272@cumc.columbia.edu
212-304-7806
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE